These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 19414323)

  • 1. The contribution of vascular endothelial growth factor to the induction of regulatory T-cells in malignant effusions.
    Wada J; Suzuki H; Fuchino R; Yamasaki A; Nagai S; Yanai K; Koga K; Nakamura M; Tanaka M; Morisaki T; Katano M
    Anticancer Res; 2009 Mar; 29(3):881-8. PubMed ID: 19414323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD4+CD25+ regulatory T lymphocytes in malignant pleural effusion.
    Chen YQ; Shi HZ; Qin XJ; Mo WN; Liang XD; Huang ZX; Yang HB; Wu C
    Am J Respir Crit Care Med; 2005 Dec; 172(11):1434-9. PubMed ID: 16151041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory T-cells are possible effect prediction markers of immunotherapy for cancer patients.
    Wada J; Yamasaki A; Nagai S; Yanai K; Fuchino K; Kameda C; Tanaka H; Koga K; Nakashima H; Nakamura M; Tanaka M; Katano M; Morisaki T
    Anticancer Res; 2008; 28(4C):2401-8. PubMed ID: 18751426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential involvement of vascular endothelial growth factor in the survival of hypoxic colon cancer cells.
    Calvani M; Trisciuoglio D; Bergamaschi C; Shoemaker RH; Melillo G
    Cancer Res; 2008 Jan; 68(1):285-91. PubMed ID: 18172321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-infiltrating regulatory T cells are positively correlated with angiogenic status in renal cell carcinoma.
    Ning H; Shao QQ; Ding KJ; Gao DX; Lu QL; Cao QW; Niu ZH; Fu Q; Zhang CH; Qu X; Lü JJ
    Chin Med J (Engl); 2012 Jun; 125(12):2120-5. PubMed ID: 22884140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surface-bound TGF-beta1 on effusion-derived exosomes participates in maintenance of number and suppressive function of regulatory T-cells in malignant effusions.
    Wada J; Onishi H; Suzuki H; Yamasaki A; Nagai S; Morisaki T; Katano M
    Anticancer Res; 2010 Sep; 30(9):3747-57. PubMed ID: 20944164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapamycin, unlike cyclosporine A, enhances suppressive functions of in vitro-induced CD4+CD25+ Tregs.
    Bocian K; Borysowski J; Wierzbicki P; Wyzgal J; Klosowska D; Bialoszewska A; Paczek L; Górski A; Korczak-Kowalska G
    Nephrol Dial Transplant; 2010 Mar; 25(3):710-7. PubMed ID: 19903662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal anti-vascular endothelial growth factor antibody reduces fluid volume in an experimental model of inflammatory pleural effusion.
    Ribeiro SC; Vargas FS; Antonangelo L; Marchi E; Genofre EH; Acencio MM; Teixeira LR
    Respirology; 2009 Nov; 14(8):1188-93. PubMed ID: 19818055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutralization of interleukin-10 or transforming growth factor-β decreases the percentages of CD4+ CD25+ Foxp3+ regulatory T cells in septic mice, thereby leading to an improved survival.
    Hiraki S; Ono S; Tsujimoto H; Kinoshita M; Takahata R; Miyazaki H; Saitoh D; Hase K
    Surgery; 2012 Feb; 151(2):313-22. PubMed ID: 21982068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor blockade reduces intratumoral regulatory T cells and enhances the efficacy of a GM-CSF-secreting cancer immunotherapy.
    Li B; Lalani AS; Harding TC; Luan B; Koprivnikar K; Huan Tu G; Prell R; VanRoey MJ; Simmons AD; Jooss K
    Clin Cancer Res; 2006 Nov; 12(22):6808-16. PubMed ID: 17121902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of tumor necrosis factor-α induced protein 8 like-2 contributes to the immunosuppressive property of CD4(+)CD25(+) regulatory T cells in mice.
    Luan YY; Yao YM; Zhang L; Dong N; Zhang QH; Yu Y; Sheng ZY
    Mol Immunol; 2011 Oct; 49(1-2):219-26. PubMed ID: 21963221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of NK T-like CD3+CD56+ cells and CD4+CD25+(hi) regulatory T cells with VEGF and TNFalpha in ascites from advanced ovarian cancer: Association with platinum resistance and prognosis in patients receiving first-line, platinum-based chemotherapy.
    Bamias A; Koutsoukou V; Terpos E; Tsiatas ML; Liakos C; Tsitsilonis O; Rodolakis A; Voulgaris Z; Vlahos G; Papageorgiou T; Papatheodoridis G; Archimandritis A; Antsaklis A; Dimopoulos MA
    Gynecol Oncol; 2008 Feb; 108(2):421-7. PubMed ID: 18036640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial growth factor levels and induction of permeability in malignant pleural effusions.
    Zebrowski BK; Yano S; Liu W; Shaheen RM; Hicklin DJ; Putnam JB; Ellis LM
    Clin Cancer Res; 1999 Nov; 5(11):3364-8. PubMed ID: 10589746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood.
    Ahn JS; Krishnadas DK; Agrawal B
    Int Immunol; 2007 Mar; 19(3):227-37. PubMed ID: 17289657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of vascular endothelial growth factor reduces scar formation after glaucoma filtration surgery.
    Li Z; Van Bergen T; Van de Veire S; Van de Vel I; Moreau H; Dewerchin M; Maudgal PC; Zeyen T; Spileers W; Moons L; Stalmans I
    Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5217-25. PubMed ID: 19474408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiopoietin 2 is a potential mediator of high-dose interleukin 2-induced vascular leak.
    Gallagher DC; Bhatt RS; Parikh SM; Patel P; Seery V; McDermott DF; Atkins MB; Sukhatme VP
    Clin Cancer Res; 2007 Apr; 13(7):2115-20. PubMed ID: 17404094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesothelioma environment comprises cytokines and T-regulatory cells that suppress immune responses.
    Hegmans JP; Hemmes A; Hammad H; Boon L; Hoogsteden HC; Lambrecht BN
    Eur Respir J; 2006 Jun; 27(6):1086-95. PubMed ID: 16540497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory T cells in chronic hepatitis B patients affect the immunopathogenesis of hepatocellular carcinoma by suppressing the anti-tumour immune responses.
    Zhang HH; Mei MH; Fei R; Liu F; Wang JH; Liao WJ; Qin LL; Wei L; Chen HS
    J Viral Hepat; 2010 Mar; 17 Suppl 1():34-43. PubMed ID: 20586932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of surface markers on peripheral CD4+CD25high T cells in patients with atopic asthma: role of inhaled corticosteroid.
    Zhang Q; Qian FH; Liu H; Zhou LF; Huang M; Zhang XL; Yin KS
    Chin Med J (Engl); 2008 Feb; 121(3):205-12. PubMed ID: 18298910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor-beta1-induced CD4+CD25+ regulatory T cells in vitro reverse and prevent a murine lupus-like syndrome of chronic graft-versus-host disease.
    Su H; Ye DQ; Wang BL; Fang XH; Chen J; Wang Q; Li WX; Zhang N
    Br J Dermatol; 2008 Jun; 158(6):1197-209. PubMed ID: 18410422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.